Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples

Marie Katrine Klose Nielsen; Michael Nedahl; Sys Stybe Johansen; Kristian Linnet

doi:10.1002/dta.2359

Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples

Marie Katrine Klose Nielsen, Michael Nedahl, Sys Stybe Johansen, Kristian Linnet

Afdeling for Retskemi

14 Citationer (Scopus)

Abstract

In this study, we present the validation of an analytical method capable of quantifying 30 commonly encountered pharmaceuticals and metabolites in whole blood and brain tissue from forensic cases. Solid‐phase extraction was performed by a fully automated robotic system, thereby minimising manual labour and human error while increasing sample throughput, robustness, and traceability. The method was validated in blood in terms of selectivity, linear range, matrix effect, extraction recovery, process efficiency, carry‐over, stability, precision, and accuracy. Deuterated analogues of each analyte were used as internal standards, which corrected adequately for any inter‐individual variability in matrix effects on analyte accuracy and precision. The lower limit of quantification (LLOQ) spanned from 0.0008 to 0.010 mg/kg, depending on the analyte, while the upper LOQ ranged between 0.40 and 2.0 mg/kg. Thus, the linear range covered both therapeutic and toxic levels. The method showed acceptable accuracy and precision, with accuracies ranging from 80 to 118% and precision below 19% for the majority of the analytes. Linear range, matrix effect, extraction recovery, process efficiency, precision, and accuracy were also tested in brain homogenate and the results agreed with those from blood. An additional finding was that the analyte concentrations in brain samples could be quantified by calibration curves obtained from spiked blood samples with acceptable precision and accuracy when using deuterated analogues of each analyte as internal standards. This method has been successfully implemented as a routine analysis procedure for quantification of pharmaceuticals in both blood and brain tissue since 2015.

Originalsprog	Engelsk
Tidsskrift	Drug Testing and Analysis
Vol/bind	10
Udgave nummer	7
Sider (fra-til)	1147-1157
ISSN	1942-7603
DOI	https://doi.org/10.1002/dta.2359
Status	Udgivet - jul. 2018

Emneord

Det Sundhedsvidenskabelige Fakultet
Automated SPE
Brain tissue
Post-mortem toxicology
UHPLC-MS/MS
Whole blood

Adgang til dokumentet

10.1002/dta.2359

Citationsformater

Nielsen, M. K. K., Nedahl, M., Johansen, S. S., & Linnet, K. (2018). Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples. Drug Testing and Analysis, 10(7), 1147-1157. https://doi.org/10.1002/dta.2359

Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples. / Nielsen, Marie Katrine Klose ; Nedahl, Michael ; Johansen, Sys Stybe et al.

I: Drug Testing and Analysis, Bind 10, Nr. 7, 07.2018, s. 1147-1157.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Nielsen, MKK , Nedahl, M , Johansen, SS & Linnet, K 2018, 'Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples', Drug Testing and Analysis, bind 10, nr. 7, s. 1147-1157. https://doi.org/10.1002/dta.2359

Nielsen, Marie Katrine Klose ; Nedahl, Michael ; Johansen, Sys Stybe et al. / Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples. I: Drug Testing and Analysis. 2018 ; Bind 10, Nr. 7. s. 1147-1157.

@article{3c61322527254ac6ab549daea2576524,

title = "Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples",

abstract = "In this study, we present the validation of an analytical method capable of quantifying 30 commonly encountered pharmaceuticals and metabolites in whole blood and brain tissue from forensic cases. Solid‐phase extraction was performed by a fully automated robotic system, thereby minimising manual labour and human error while increasing sample throughput, robustness, and traceability. The method was validated in blood in terms of selectivity, linear range, matrix effect, extraction recovery, process efficiency, carry‐over, stability, precision, and accuracy. Deuterated analogues of each analyte were used as internal standards, which corrected adequately for any inter‐individual variability in matrix effects on analyte accuracy and precision. The lower limit of quantification (LLOQ) spanned from 0.0008 to 0.010 mg/kg, depending on the analyte, while the upper LOQ ranged between 0.40 and 2.0 mg/kg. Thus, the linear range covered both therapeutic and toxic levels. The method showed acceptable accuracy and precision, with accuracies ranging from 80 to 118% and precision below 19% for the majority of the analytes. Linear range, matrix effect, extraction recovery, process efficiency, precision, and accuracy were also tested in brain homogenate and the results agreed with those from blood. An additional finding was that the analyte concentrations in brain samples could be quantified by calibration curves obtained from spiked blood samples with acceptable precision and accuracy when using deuterated analogues of each analyte as internal standards. This method has been successfully implemented as a routine analysis procedure for quantification of pharmaceuticals in both blood and brain tissue since 2015. ",

keywords = "Faculty of Health and Medical Sciences, Automated SPE, Brain tissue, Post-mortem toxicology, UHPLC-MS/MS, Whole blood",

author = "Nielsen, {Marie Katrine Klose} and Michael Nedahl and Johansen, {Sys Stybe} and Kristian Linnet",

year = "2018",

month = jul,

doi = "10.1002/dta.2359",

language = "English",

volume = "10",

pages = "1147--1157",

journal = "Drug Testing and Analysis",

issn = "1942-7603",

publisher = "JohnWiley & Sons Ltd",

number = "7",

}

TY - JOUR

T1 - Validation of a fully automated solid‐phase extraction and ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post‐mortem blood and brain samples

AU - Nielsen, Marie Katrine Klose

AU - Nedahl, Michael

AU - Johansen, Sys Stybe

AU - Linnet, Kristian

PY - 2018/7

Y1 - 2018/7

N2 - In this study, we present the validation of an analytical method capable of quantifying 30 commonly encountered pharmaceuticals and metabolites in whole blood and brain tissue from forensic cases. Solid‐phase extraction was performed by a fully automated robotic system, thereby minimising manual labour and human error while increasing sample throughput, robustness, and traceability. The method was validated in blood in terms of selectivity, linear range, matrix effect, extraction recovery, process efficiency, carry‐over, stability, precision, and accuracy. Deuterated analogues of each analyte were used as internal standards, which corrected adequately for any inter‐individual variability in matrix effects on analyte accuracy and precision. The lower limit of quantification (LLOQ) spanned from 0.0008 to 0.010 mg/kg, depending on the analyte, while the upper LOQ ranged between 0.40 and 2.0 mg/kg. Thus, the linear range covered both therapeutic and toxic levels. The method showed acceptable accuracy and precision, with accuracies ranging from 80 to 118% and precision below 19% for the majority of the analytes. Linear range, matrix effect, extraction recovery, process efficiency, precision, and accuracy were also tested in brain homogenate and the results agreed with those from blood. An additional finding was that the analyte concentrations in brain samples could be quantified by calibration curves obtained from spiked blood samples with acceptable precision and accuracy when using deuterated analogues of each analyte as internal standards. This method has been successfully implemented as a routine analysis procedure for quantification of pharmaceuticals in both blood and brain tissue since 2015.

AB - In this study, we present the validation of an analytical method capable of quantifying 30 commonly encountered pharmaceuticals and metabolites in whole blood and brain tissue from forensic cases. Solid‐phase extraction was performed by a fully automated robotic system, thereby minimising manual labour and human error while increasing sample throughput, robustness, and traceability. The method was validated in blood in terms of selectivity, linear range, matrix effect, extraction recovery, process efficiency, carry‐over, stability, precision, and accuracy. Deuterated analogues of each analyte were used as internal standards, which corrected adequately for any inter‐individual variability in matrix effects on analyte accuracy and precision. The lower limit of quantification (LLOQ) spanned from 0.0008 to 0.010 mg/kg, depending on the analyte, while the upper LOQ ranged between 0.40 and 2.0 mg/kg. Thus, the linear range covered both therapeutic and toxic levels. The method showed acceptable accuracy and precision, with accuracies ranging from 80 to 118% and precision below 19% for the majority of the analytes. Linear range, matrix effect, extraction recovery, process efficiency, precision, and accuracy were also tested in brain homogenate and the results agreed with those from blood. An additional finding was that the analyte concentrations in brain samples could be quantified by calibration curves obtained from spiked blood samples with acceptable precision and accuracy when using deuterated analogues of each analyte as internal standards. This method has been successfully implemented as a routine analysis procedure for quantification of pharmaceuticals in both blood and brain tissue since 2015.

KW - Faculty of Health and Medical Sciences

KW - Automated SPE

KW - Brain tissue

KW - Post-mortem toxicology

KW - UHPLC-MS/MS

KW - Whole blood

U2 - 10.1002/dta.2359

DO - 10.1002/dta.2359

M3 - Journal article

C2 - 29341495

SN - 1942-7603

VL - 10

SP - 1147

EP - 1157

JO - Drug Testing and Analysis

JF - Drug Testing and Analysis

IS - 7

ER -